ARCHIVES

ODACSupports Temodal For Treatment of Astrocytoma

This article is from The Cancer Letter archive.

Vol. 25 No. 03 | January 22, 1999

Download PDF Visit The Full Archive

Related Articles

MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues

November 29, 2013

NIH appoints panel to review conflict of interest rules.

February 27, 2004

Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions

August 16, 1991

Mysterious Group Urges Letters In Support Of Fisher, Calls For Investigation of NCI

April 22, 1994

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979